Why WhizAI for Analysts and Data Scientists
- Ability to leverage real-world patient data to get deeper, faster insights and assess market dynamics via an easy self-service platform
- No restrictions on data volume and slicing-dicing options available without writing comprehensive SQL queries
- Easy, user-friendly and understandable drill down of patient claims data
- Conduct ad-hoc analysis at scale in a zero-code environment to figure out the right data sources and readily uncover hidden patterns
Data Source Exploration
Explore and select most relevant data sources from hundreds of in-house real-world data sources based on criteria of interest.
Market Sizing and Profiling
Understand the market dynamics and size for multiple therapy areas by assessing the number and profile of patients across multiple disease areas.
Patient Profiling by Social Determinants of Health (SDoH)
Profile patients and treatment differences by social determinants of health such as age, gender, income, location, etc.
Product Utilization by Diagnosis
Evaluate and compare product utilization for market drugs by diagnosis. Understand the distribution of diagnoses, procedures, and treatment of interest by patient age and gender.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Gartner® Predicts Augmented Analytics Will Have a Major Impact on Life Sciences Commercial Functions
Gartner recognizes WhizAI as a Sample Vendor for Augmented Analytics, an emerging technology poised to revolutionize how commercial teams use data insights to optimize outcomes.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
WhizAI Deployed as a New Field Reporting System at a Top 3 Global Pharma
Better, Faster, Smarter Decisions at Lower Cost for a Top 3 Global Pharma. A top 3 global pharmaceutical faced the following challenges with their legacy field reporting system:
WhizAI Puts Sales Reps at the Center of the Analytics Process for a Leading Specialty Pharmaceutical Company
Sales reps use WhizAI data exploration to answer questions like 'Sales trends this year by region, brand (or by city, territory, GPO, COT, IDN)?' in seconds.